These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33395099)

  • 1. Animal models of neurodevelopmental disorders with behavioral phenotypes.
    Harris JC
    Curr Opin Psychiatry; 2021 Mar; 34(2):87-93. PubMed ID: 33395099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications.
    Delling JP; Boeckers TM
    J Neurodev Disord; 2021 Nov; 13(1):55. PubMed ID: 34784886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral Phenotyping of an Improved Mouse Model of Phelan-McDermid Syndrome with a Complete Deletion of the
    Drapeau E; Riad M; Kajiwara Y; Buxbaum JD
    eNeuro; 2018; 5(3):. PubMed ID: 30302388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Rett Syndrome Using TALEN-Edited MECP2 Mutant Cynomolgus Monkeys.
    Chen Y; Yu J; Niu Y; Qin D; Liu H; Li G; Hu Y; Wang J; Lu Y; Kang Y; Jiang Y; Wu K; Li S; Wei J; He J; Wang J; Liu X; Luo Y; Si C; Bai R; Zhang K; Liu J; Huang S; Chen Z; Wang S; Chen X; Bao X; Zhang Q; Li F; Geng R; Liang A; Shen D; Jiang T; Hu X; Ma Y; Ji W; Sun YE
    Cell; 2017 May; 169(5):945-955.e10. PubMed ID: 28525759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.
    Harony-Nicolas H; De Rubeis S; Kolevzon A; Buxbaum JD
    J Child Neurol; 2015 Dec; 30(14):1861-70. PubMed ID: 26350728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological read-through of R294X Mecp2 in a novel mouse model of Rett syndrome.
    Merritt JK; Collins BE; Erickson KR; Dong H; Neul JL
    Hum Mol Genet; 2020 Aug; 29(15):2461-2470. PubMed ID: 32469049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phelan-McDermid Syndrome and SHANK3: Implications for Treatment.
    Costales JL; Kolevzon A
    Neurotherapeutics; 2015 Jul; 12(3):620-30. PubMed ID: 25894671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in Mecp2-mutant Rett syndrome model mice and the impact of cellular mosaicism in phenotype development.
    Ribeiro MC; MacDonald JL
    Brain Res; 2020 Feb; 1729():146644. PubMed ID: 31904347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroanatomy in mouse models of Rett syndrome is related to the severity of Mecp2 mutation and behavioral phenotypes.
    Allemang-Grand R; Ellegood J; Spencer Noakes L; Ruston J; Justice M; Nieman BJ; Lerch JP
    Mol Autism; 2017; 8():32. PubMed ID: 28670438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental social communication deficits in the Shank3 rat model of phelan-mcdermid syndrome and autism spectrum disorder.
    Berg EL; Copping NA; Rivera JK; Pride MC; Careaga M; Bauman MD; Berman RF; Lein PJ; Harony-Nicolas H; Buxbaum JD; Ellegood J; Lerch JP; Wöhr M; Silverman JL
    Autism Res; 2018 Apr; 11(4):587-601. PubMed ID: 29377611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dawn of non-human primate models for neurodevelopmental disorders.
    Aida T; Feng G
    Curr Opin Genet Dev; 2020 Dec; 65():160-168. PubMed ID: 32693220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of two Shank3 and the Cacna1c mouse models of autism spectrum disorder.
    Kabitzke PA; Brunner D; He D; Fazio PA; Cox K; Sutphen J; Thiede L; Sabath E; Hanania T; Alexandrov V; Rasmusson R; Spooren W; Ghosh A; Feliciano P; Biemans B; Benedetti M; Clayton AL
    Genes Brain Behav; 2018 Jan; 17(1):4-22. PubMed ID: 28753255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome.
    Young JI; Zoghbi HY
    Am J Hum Genet; 2004 Mar; 74(3):511-20. PubMed ID: 14973779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and therapeutic challenges in autism spectrum disorders: insights from Rett syndrome.
    Castro J; Mellios N; Sur M
    Curr Opin Neurol; 2013 Apr; 26(2):154-9. PubMed ID: 23449173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Neurological Manifestations of Phelan-McDermid Syndrome.
    Frank Y
    Pediatr Neurol; 2021 Sep; 122():59-64. PubMed ID: 34325981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities.
    Leach PT; Crawley JN
    Genes Brain Behav; 2018 Jul; 17(6):e12452. PubMed ID: 29266714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by
    De Rubeis S; Siper PM; Durkin A; Weissman J; Muratet F; Halpern D; Trelles MDP; Frank Y; Lozano R; Wang AT; Holder JL; Betancur C; Buxbaum JD; Kolevzon A
    Mol Autism; 2018; 9():31. PubMed ID: 29719671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene.
    Pitcher MR; Herrera JA; Buffington SA; Kochukov MY; Merritt JK; Fisher AR; Schanen NC; Costa-Mattioli M; Neul JL
    Hum Mol Genet; 2015 May; 24(9):2662-72. PubMed ID: 25634563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental loss of MeCP2 from VIP interneurons impairs cortical function and behavior.
    Mossner JM; Batista-Brito R; Pant R; Cardin JA
    Elife; 2020 Apr; 9():. PubMed ID: 32343226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe white matter damage in SHANK3 deficiency: a human and translational study.
    Jesse S; Müller HP; Schoen M; Asoglu H; Bockmann J; Huppertz HJ; Rasche V; Ludolph AC; Boeckers TM; Kassubek J
    Ann Clin Transl Neurol; 2020 Jan; 7(1):46-58. PubMed ID: 31788990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.